Friday 6 November 2026 Export GRAL’s income statement to Excel — free account

GRAIL, Inc.

GRAL Healthcare Diagnostics & Research

GRAIL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $147.2 million, up 17.2% from fiscal 2024.

Revenue: +3.71%
EPS: +10.2%
Free cash flow: −24.9%

Quarter to September 2026, against a year earlier

Revenue growth 3 yrs

121.97 2.84 +2.38%

Follow GRAL

Alert me

Market cap: $5.3B
P/E: 0.0×
Fwd P/E: −14.5×
Dividend yield: —
F-score: 6/9
Altman Z: 0.37
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

GRAIL, Inc. 10-K filed Mar 12, 2026

Fiscal year 2025 · Period ended Dec 31, 2025 · Filed Mar 12, 2026 · accepted 4:40 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1A, Risk Factors, against the 10-K filed Mar 5, 2025: 45 added · 18 removed · 169 modified; 1 with only figures updated